Swiss National Bank Karyopharm Therapeutics Inc. Transaction History

Swiss National Bank

$150 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$1.79 - $4.59 $14,678 - $37,638	-8,200 Reduced 3.54%	223,350 $399,000
Q1 2023 May 10, 2023	SELL	$2.84 - $3.92 $78,384 - $108,192	-27,600 Reduced 10.65%	231,550 $900,000
Q4 2022 Feb 08, 2023	BUY	$2.48 - $5.93 $222,456 - $531,921	89,700 Added 52.94%	259,150 $881,000
Q3 2022 Nov 09, 2022	BUY	$4.08 - $5.82 $35,496 - $50,634	8,700 Added 5.41%	169,450 $925,000
Q1 2022 May 09, 2022	BUY	$5.91 - $14.38 $66,783 - $162,494	11,300 Added 7.56%	160,750 $1.19 Million
Q4 2021 Feb 08, 2022	BUY	$5.21 - $8.61 $92,738 - $153,258	17,800 Added 13.52%	149,450 $961,000
Q2 2021 Aug 06, 2021	BUY	$8.11 - $11.11 $112,728 - $154,429	13,900 Added 11.8%	131,650 $1.36 Million
Q1 2021 May 07, 2021	BUY	$9.85 - $17.69 $16,745 - $30,073	1,700 Added 1.46%	117,750 $1.24 Million
Q3 2020 Nov 09, 2020	BUY	$14.14 - $19.71 $192,304 - $268,056	13,600 Added 13.27%	116,050 $1.69 Million
Q2 2020 Aug 05, 2020	BUY	$16.6 - $25.25 $83,000 - $126,250	5,000 Added 5.13%	102,450 $1.94 Million
Q1 2020 May 08, 2020	BUY	$14.38 - $27.72 $38,826 - $74,844	2,700 Added 2.85%	97,450 $1.87 Million
Q4 2019 Feb 06, 2020	BUY	$9.23 - $19.67 $38,766 - $82,614	4,200 Added 4.64%	94,750 $1.82 Million
Q2 2019 Aug 02, 2019	BUY	$4.32 - $6.43 $23,328 - $34,722	5,400 Added 6.34%	90,550 $542,000
Q2 2018 Aug 09, 2018	BUY	$12.0 - $19.88 $252,000 - $417,480	21,000 Added 32.74%	85,150 $1.45 Million
Q1 2018 May 04, 2018	BUY	$9.92 - $17.25 $72,416 - $125,925	7,300 Added 12.84%	64,150 $861,000
Q3 2017 Nov 03, 2017	BUY	$8.15 - $11.16 $463,327 - $634,446	56,850	56,850 $624,000

Others Institutions Holding KPTI

# of Institutions

Shares Held

57.6M

Call Options Held

258K

Put Options Held

81.2K

Vanguard Group Inc Valley Forge, PA

7.65M
Shares

$5.13 Million
0.0% of portfolio
Eversept Partners, LP New York, NY

5.55M
Shares

$3.72 Million
0.36% of portfolio
Palo Alto Investors LP Palo Alto, CA

5.1M
Shares

$3.42 Million
0.58% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

4.32M
Shares

$2.89 Million
0.01% of portfolio
Black Rock Inc. New York, NY

4.17M
Shares

$2.79 Million
0.0% of portfolio

View Full List

About Karyopharm Therapeutics Inc.

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $53.5M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

More about KPTI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account